The Influence of KDR Genetic Variation on the Efficacy and Safety of Patients With Advanced NSCLC Receiving First-Line Bevacizumab Plus Chemotherapy Regimen

OBJECTIVE: Angiogenesis plays an important role in the growth and metastasis of non-small cell lung cancer (NSCLC). Bevacizumab is a humanized monoclonal antibody that mainly acts on vascular endothelial growth factor A (VEGFA). Kinase insert domain receptor (KDR) is the most important target of VEG...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Nan, Su, Jingwei, Liu, Zhikun, Ding, Cuimin, Xie, Shaonan, Hu, Wenxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173991/
https://www.ncbi.nlm.nih.gov/pubmed/34060368
http://dx.doi.org/10.1177/15330338211019433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173991/
https://www.ncbi.nlm.nih.gov/pubmed/34060368
http://dx.doi.org/10.1177/15330338211019433

Ejemplares similares